Alnylam Pharmaceuticals Ownership 2024 | Who Owns Alnylam Pharmaceuticals Now?
Institutional Ownership
95.02%
Insider Ownership
0.42%
Retail Ownership
4.56%
Institutional Holders
560.00
Alnylam Pharmaceuticals Institutional Shareholders
Institutional Shareholders by % of Total Shares
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
CAPITAL WORLD INVESTORS | 11.87% | 0.59% | 14,971,343 | 2,182,107 | 17.06% | 3,638,104,641 | Jun 30, 2024 |
VANGUARD GROUP INC | 9.92% | 0.06% | 12,507,778 | 513,517 | 4.28% | 3,039,390,054 | Jun 30, 2024 |
FMR LLC | 9.64% | 0.19% | 12,164,038 | 2,196,042 | 22.03% | 2,955,861,341 | Jun 30, 2024 |
BLACKROCK INC. | 7.57% | 0.05% | 9,547,663 | 522,656 | 5.79% | 2,320,082,109 | Jun 30, 2024 |
WELLINGTON MANAGEMENT GROUP LLP | 4.92% | 0.27% | 6,210,479 | -998,526 | -13.85% | 1,509,146,397 | Jun 30, 2024 |
BAILLIE GIFFORD & CO | 4.78% | 1.14% | 6,032,656 | -590,921 | -8.92% | 1,465,935,408 | Jun 30, 2024 |
CAPITAL INTERNATIONAL INVESTORS | 3.08% | 0.19% | 3,891,059 | 239,842 | 6.57% | 945,651,452 | Jun 30, 2024 |
DODGE & COX | 3.00% | 0.55% | 3,780,185 | -31,295 | -0.82% | 918,584,955 | Jun 30, 2024 |
STATE STREET CORP | 2.80% | 0.04% | 3,534,836 | 343,463 | 10.76% | 858,965,148,000 | Jun 30, 2024 |
PRICE T ROWE ASSOCIATES INC /MD/ | 2.77% | 0.10% | 3,488,003 | -197,750 | -5.37% | 847,586,000 | Jun 30, 2024 |
CAPITAL RESEARCH GLOBAL INVESTORS | 2.58% | 0.17% | 3,255,648 | 110,661 | 3.52% | 791,139,627 | Jun 30, 2024 |
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 2.50% | 0.48% | 3,153,627 | 280,723 | 9.77% | 766,332,000 | Jun 30, 2024 |
NORGES BANK | 1.82% | 0.08% | 2,296,781 | 2,296,781 | 100.00% | 558,117,783 | Jun 30, 2024 |
GEODE CAPITAL MANAGEMENT, LLC | 1.65% | 0.04% | 2,080,275 | 78,557 | 3.92% | 504,599,030 | Jun 30, 2024 |
JPMORGAN CHASE & CO | 1.41% | 0.04% | 1,772,871 | 24,682 | 1.41% | 430,807,702 | Jun 30, 2024 |
AMERICAN CENTURY COMPANIES INC | 1.07% | 0.20% | 1,354,169 | -19,485 | -1.42% | 329,063,460 | Jun 30, 2024 |
LEGAL & GENERAL GROUP PLC | 0.73% | 0.05% | 926,330 | 5,135 | 0.56% | 225,098,405 | Jun 30, 2024 |
BELLEVUE GROUP AG | 0.73% | 3.63% | 919,834 | 1,550 | 0.17% | 223,519,662 | Jun 30, 2024 |
UBS ASSET MANAGEMENT AMERICAS INC | 0.66% | 0.06% | 835,413 | 76,763 | 10.12% | 203,005,359 | Jun 30, 2024 |
NORTHERN TRUST CORP | 0.62% | 0.03% | 780,835 | 41,251 | 5.58% | 189,742,905,000 | Jun 30, 2024 |
Alnylam Pharmaceuticals's largest institutional shareholder is CAPITAL WORLD INVESTORS, holding 11.87% of the company's total share outstanding, currently valued at $3.64B. The top 10 institutional shareholders own together 60.35% of the company.
Institutional Shareholders by % of Total Assets
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
IKARIAN CAPITAL, LLC | 0.00% | 6.35% | 1,500 | -119,300 | -98.76% | 36,450,000 | Jun 30, 2024 |
GHOST TREE CAPITAL, LLC | 0.05% | 5.20% | 68,400 | 68,400 | 100.00% | 16,621,200 | Jun 30, 2024 |
BRIDGER MANAGEMENT, LLC | 0.03% | 4.63% | 37,022 | -15,900 | -30.04% | 8,996,346 | Jun 30, 2024 |
BELLEVUE GROUP AG | 0.73% | 3.63% | 919,834 | 1,550 | 0.17% | 223,519,662 | Jun 30, 2024 |
DEEP TRACK CAPITAL, LP | 0.40% | 3.63% | 500,000 | -332,310 | -39.93% | 121,500,000 | Jun 30, 2024 |
EAGLE HEALTH INVESTMENTS LP | 0.06% | 3.25% | 76,256 | 27,900 | 57.70% | 18,530,208 | Jun 30, 2024 |
CASDIN CAPITAL, LLC | 0.13% | 3.17% | 170,000 | -188,000 | -52.51% | 41,310,000 | Jun 30, 2024 |
TRI LOCUM PARTNERS LP | 0.04% | 2.76% | 45,000 | 45,000 | 100.00% | 10,935,000 | Jun 30, 2024 |
AVIDITY PARTNERS MANAGEMENT LP | 0.18% | 2.29% | 222,000 | -21,000 | -8.64% | 53,946,000 | Jun 30, 2024 |
ROSENBLUM SILVERMAN SUTTON S F INC /CA | 0.03% | 2.29% | 35,200 | -270 | -0.76% | 8,553,600 | Jun 30, 2024 |
683 CAPITAL MANAGEMENT, LLC | 0.10% | 2.26% | 122,900 | 87,100 | 243.30% | 29,864,700 | Jun 30, 2024 |
ANTIPODES PARTNERS LTD | 0.19% | 2.16% | 238,749 | 33,170 | 16.13% | 59,431,740 | Jun 30, 2024 |
SILVERARC CAPITAL MANAGEMENT, LLC | 0.03% | 2.06% | 36,000 | 36,000 | 100.00% | 8,748,000 | Jun 30, 2024 |
RHENMAN & PARTNERS ASSET MANAGEMENT AB | 0.07% | 1.99% | 85,500 | 43,200 | 102.13% | 20,776,500 | Jun 30, 2024 |
SOFINNOVA INVESTMENTS, INC. | 0.12% | 1.87% | 147,929 | 44,893 | 43.57% | 35,946,747 | Jun 30, 2024 |
CAPTION MANAGEMENT, LLC | 0.39% | 1.83% | 489,600 | 378,300 | 339.89% | 118,972,800 | Jun 30, 2024 |
ROCK SPRINGS CAPITAL MANAGEMENT LP | 0.20% | 1.83% | 250,000 | 6,000 | 2.46% | 60,750,000 | Jun 30, 2024 |
GHOST TREE CAPITAL, LLC | 0.02% | 1.71% | 22,500 | -37,500 | -62.50% | 5,467,500 | Jun 30, 2024 |
NOVO HOLDINGS A/S | 0.09% | 1.67% | 118,383 | - | - | 28,767,069 | Jun 30, 2024 |
ARTIA GLOBAL PARTNERS LP | 0.03% | 1.64% | 35,000 | 35,000 | 100.00% | 8,505,000 | Jun 30, 2024 |
The largest Alnylam Pharmaceuticals shareholder by % of total assets is IKARIAN CAPITAL, LLC. The company owns 1.50K shares of Alnylam Pharmaceuticals (ALNY), representing 6.35% of its total assets.
Institutional Buyers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
NORGES BANK | 1.82% | 0.08% | 2,296,781 | 2,296,781 | 100.00% | 558,117,783 | Jun 30, 2024 |
FMR LLC | 9.64% | 0.19% | 12,164,038 | 2,196,042 | 22.03% | 2,955,861,341 | Jun 30, 2024 |
CAPITAL WORLD INVESTORS | 11.87% | 0.59% | 14,971,343 | 2,182,107 | 17.06% | 3,638,104,641 | Jun 30, 2024 |
ORBIS ALLAN GRAY LTD | 0.57% | 1.09% | 721,053 | 721,053 | 100.00% | 175,215,879 | Jun 30, 2024 |
BLACKROCK INC. | 7.57% | 0.05% | 9,547,663 | 522,656 | 5.79% | 2,320,082,109 | Jun 30, 2024 |
VANGUARD GROUP INC | 9.92% | 0.06% | 12,507,778 | 513,517 | 4.28% | 3,039,390,054 | Jun 30, 2024 |
CAPTION MANAGEMENT, LLC | 0.39% | 1.83% | 489,600 | 378,300 | 339.89% | 118,972,800 | Jun 30, 2024 |
STATE STREET CORP | 2.80% | 0.04% | 3,534,836 | 343,463 | 10.76% | 858,965,148,000 | Jun 30, 2024 |
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 2.50% | 0.48% | 3,153,627 | 280,723 | 9.77% | 766,332,000 | Jun 30, 2024 |
GOLDMAN SACHS GROUP INC | 0.41% | 0.02% | 514,667 | 254,648 | 97.93% | 125,063,967 | Jun 30, 2024 |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 0.20% | 0.11% | 254,000 | 254,000 | 100.00% | 61,722,000 | Jun 30, 2024 |
ORBIMED ADVISORS LLC | 0.20% | 1.21% | 250,300 | 250,300 | 100.00% | 60,822,900 | Jun 30, 2024 |
CAPITAL INTERNATIONAL INVESTORS | 3.08% | 0.19% | 3,891,059 | 239,842 | 6.57% | 945,651,452 | Jun 30, 2024 |
INVESCO LTD. | 0.31% | 0.02% | 392,841 | 214,528 | 120.31% | 95,460,363 | Jun 30, 2024 |
D. E. SHAW & CO., INC. | 0.22% | 0.06% | 279,398 | 176,011 | 170.24% | 67,893,714 | Jun 30, 2024 |
FRONTIER CAPITAL MANAGEMENT CO LLC | 0.13% | 0.41% | 168,442 | 168,442 | 100.00% | 40,931,406 | Jun 30, 2024 |
BANK OF AMERICA CORP /DE/ | 0.50% | 0.01% | 631,112 | 146,219 | 30.15% | 153,360,216 | Jun 30, 2024 |
AQR CAPITAL MANAGEMENT LLC | 0.22% | 0.10% | 271,619 | 130,482 | 92.45% | 65,862,175 | Jun 30, 2024 |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 0.10% | 0.48% | 119,800 | 119,800 | 100.00% | 29,111,400 | Jun 30, 2024 |
LMR PARTNERS LLP | 0.17% | 0.43% | 211,900 | 112,700 | 113.61% | 51,491,700 | Jun 30, 2024 |
As of Jun 30 2024, Alnylam Pharmaceuticals's largest institutional buyer is NORGES BANK. The company purchased 2.30M stocks of ALNY, valued at $558.12M.
Institutional Sellers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
WELLINGTON MANAGEMENT GROUP LLP | 4.92% | 0.27% | 6,210,479 | -998,526 | -13.85% | 1,509,146,397 | Jun 30, 2024 |
BAILLIE GIFFORD & CO | 4.78% | 1.14% | 6,032,656 | -590,921 | -8.92% | 1,465,935,408 | Jun 30, 2024 |
LOGOS GLOBAL MANAGEMENT LP | - | - | - | -500,000 | -100.00% | - | Jun 30, 2024 |
SQUAREPOINT OPS LLC | 0.08% | 0.04% | 98,794 | -481,647 | -82.98% | 24,006,942 | Jun 30, 2024 |
VESTAL POINT CAPITAL, LP | - | - | - | -350,000 | -100.00% | - | Jun 30, 2024 |
DEEP TRACK CAPITAL, LP | 0.40% | 3.63% | 500,000 | -332,310 | -39.93% | 121,500,000 | Jun 30, 2024 |
BALYASNY ASSET MANAGEMENT L.P. | - | - | - | -287,627 | -100.00% | - | Jun 30, 2024 |
ADAR1 CAPITAL MANAGEMENT, LLC | - | - | - | -234,400 | -100.00% | - | Jun 30, 2024 |
POINT72 ASSET MANAGEMENT, L.P. | - | - | - | -206,255 | -100.00% | - | Jun 30, 2024 |
PICTET ASSET MANAGEMENT HOLDING SA | 0.60% | 0.21% | 758,528 | -202,976 | -21.11% | 184,322,304 | Jun 30, 2024 |
PRICE T ROWE ASSOCIATES INC /MD/ | 2.77% | 0.10% | 3,488,003 | -197,750 | -5.37% | 847,586,000 | Jun 30, 2024 |
SCHONFELD STRATEGIC ADVISORS LLC | 0.03% | 0.07% | 43,975 | -191,631 | -81.34% | 10,685,925 | Jun 30, 2024 |
CASDIN CAPITAL, LLC | 0.13% | 3.17% | 170,000 | -188,000 | -52.51% | 41,310,000 | Jun 30, 2024 |
PALO ALTO INVESTORS LP | - | - | - | -182,766 | -100.00% | - | Jun 30, 2024 |
ADAR1 CAPITAL MANAGEMENT, LLC | 0.00% | 0.08% | 1,850 | -178,295 | -98.97% | 449,550 | Jun 30, 2024 |
BANK OF NEW YORK MELLON CORP | 0.53% | 0.03% | 673,702 | -124,743 | -15.62% | 163,709,488 | Jun 30, 2024 |
IKARIAN CAPITAL, LLC | 0.00% | 6.35% | 1,500 | -119,300 | -98.76% | 36,450,000 | Jun 30, 2024 |
JACOBS LEVY EQUITY MANAGEMENT, INC | 0.01% | 0.01% | 13,283 | -113,084 | -89.49% | 3,227,769 | Jun 30, 2024 |
QUBE RESEARCH & TECHNOLOGIES LTD | - | - | - | -110,759 | -100.00% | - | Jun 30, 2024 |
NATIONAL BANK OF CANADA /FI/ | 0.00% | 0.00% | 626 | -107,784 | -99.42% | 152,273 | Jun 30, 2024 |
As of Jun 30 2024, Alnylam Pharmaceuticals's biggest institutional seller is WELLINGTON MANAGEMENT GROUP LLP. The company sold -1.00M shares of ALNY, valued at $1.51B.
Institutional New positions
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
NORGES BANK | 1.82% | 0.08% | 2,296,781 | 2,296,781 | 100.00% | 558,117,783 | Jun 30, 2024 |
ORBIS ALLAN GRAY LTD | 0.57% | 1.09% | 721,053 | 721,053 | 100.00% | 175,215,879 | Jun 30, 2024 |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 0.20% | 0.11% | 254,000 | 254,000 | 100.00% | 61,722,000 | Jun 30, 2024 |
FRONTIER CAPITAL MANAGEMENT CO LLC | 0.13% | 0.41% | 168,442 | 168,442 | 100.00% | 40,931,406 | Jun 30, 2024 |
HUDSON BAY CAPITAL MANAGEMENT LP | 0.08% | 0.11% | 95,000 | 95,000 | 100.00% | 23,085,000 | Jun 30, 2024 |
BANK OF AMERICA CORP /DE/ | 0.07% | 0.00% | 83,500 | 83,500 | 100.00% | 20,290,500 | Jun 30, 2024 |
SOLEUS CAPITAL MANAGEMENT, L.P. | 0.06% | 1.54% | 71,700 | 71,700 | 100.00% | 17,423,100 | Jun 30, 2024 |
GHOST TREE CAPITAL, LLC | 0.05% | 5.20% | 68,400 | 68,400 | 100.00% | 16,621,200 | Jun 30, 2024 |
TWO SIGMA SECURITIES, LLC | 0.04% | 0.16% | 54,142 | 54,142 | 100.00% | 13,156,506 | Jun 30, 2024 |
J. GOLDMAN & CO LP | 0.04% | 0.35% | 50,300 | 50,300 | 100.00% | 12,222,900 | Jun 30, 2024 |
SOFINNOVA INVESTMENTS, INC. | 0.04% | 0.63% | 50,000 | 50,000 | 100.00% | 12,150,000 | Jun 30, 2024 |
TRI LOCUM PARTNERS LP | 0.04% | 2.76% | 45,000 | 45,000 | 100.00% | 10,935,000 | Jun 30, 2024 |
KYNAM CAPITAL MANAGEMENT, LP | 0.03% | 0.81% | 43,000 | 43,000 | 100.00% | 10,449,000 | Jun 30, 2024 |
SILVERARC CAPITAL MANAGEMENT, LLC | 0.03% | 2.06% | 36,000 | 36,000 | 100.00% | 8,748,000 | Jun 30, 2024 |
ARTIA GLOBAL PARTNERS LP | 0.03% | 1.64% | 35,000 | 35,000 | 100.00% | 8,505,000 | Jun 30, 2024 |
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.02% | 0.02% | 31,293 | 31,293 | 100.00% | 7,616,531 | Jun 30, 2024 |
FJARDE AP-FONDEN (THE FOURTH SWEDISH NATIONAL PENSIONFUND) | 0.02% | 0.08% | 28,415 | 28,415 | 100.00% | 6,905,000 | Jun 30, 2024 |
ATIKA CAPITAL MANAGEMENT LLC | 0.02% | 0.58% | 24,500 | 24,500 | 100.00% | 5,953,500 | Jun 30, 2024 |
UBS OCONNOR LLC | 0.02% | 0.00% | 19,100 | 19,100 | 100.00% | 27,875 | Jun 30, 2024 |
DLD ASSET MANAGEMENT, LP | 0.01% | 0.77% | 16,200 | 16,200 | 100.00% | 3,936,600 | Jun 30, 2024 |
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 0.01% | 0.00% | 14,971 | 14,971 | 100.00% | 3,638,000 | Jun 30, 2024 |
VOLORIDGE INVESTMENT MANAGEMENT, LLC | 0.01% | 0.01% | 14,863 | 14,863 | 100.00% | 3,611,709 | Jun 30, 2024 |
MELQART ASSET MANAGEMENT (UK) LTD | 0.01% | 0.27% | 13,500 | 13,500 | 100.00% | 3,280,500 | Jun 30, 2024 |
NOMURA HOLDINGS INC | 0.01% | 0.01% | 11,300 | 11,300 | 100.00% | 2,745,900 | Jun 30, 2024 |
CENTIVA CAPITAL, LP | 0.01% | 0.04% | 10,500 | 10,500 | 100.00% | 2,551,500 | Jun 30, 2024 |
UBS OCONNOR LLC | 0.01% | 0.00% | 10,000 | 10,000 | 100.00% | 46,000 | Jun 30, 2024 |
READYSTATE ASSET MANAGEMENT LP | 0.01% | 0.08% | 9,600 | 9,600 | 100.00% | 2,332,800 | Jun 30, 2024 |
MBB PUBLIC MARKETS I LLC | 0.01% | 0.05% | 9,200 | 9,200 | 100.00% | 2,235,600 | Jun 30, 2024 |
NOMURA HOLDINGS INC | 0.01% | 0.00% | 8,800 | 8,800 | 100.00% | 2,138,400 | Jun 30, 2024 |
DEUTSCHE BANK AG\ | 0.01% | 0.00% | 8,700 | 8,700 | 100.00% | 2,114,100 | Jun 30, 2024 |
CINCTIVE CAPITAL MANAGEMENT LP | 0.01% | 0.10% | 8,300 | 8,300 | 100.00% | 2,016,900 | Jun 30, 2024 |
J. SAFRA SARASIN HOLDING AG | 0.01% | 0.03% | 6,871 | 6,871 | 100.00% | 1,669,653 | Jun 30, 2024 |
ENTROPY TECHNOLOGIES, LP | 0.01% | 0.18% | 6,849 | 6,849 | 100.00% | 1,664,307 | Jun 30, 2024 |
NOMURA HOLDINGS INC | 0.01% | 0.00% | 6,426 | 6,426 | 100.00% | 1,561,518 | Jun 30, 2024 |
INCEPTIONR LLC | 0.00% | 0.37% | 5,397 | 5,397 | 100.00% | 1,311,471 | Jun 30, 2024 |
KNOLLWOOD INVESTMENT ADVISORY, LLC | 0.00% | 0.14% | 5,355 | 5,355 | 100.00% | 1,301,265 | Jun 30, 2024 |
DIVERSIFIED TRUST CO | 0.00% | 0.03% | 4,978 | 4,978 | 100.00% | 1,209,654 | Jun 30, 2024 |
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 0.00% | 0.00% | 4,744 | 4,744 | 100.00% | 1,152,792 | Jun 30, 2024 |
OMERS ADMINISTRATION CORP | 0.00% | 0.01% | 4,361 | 4,361 | 100.00% | 1,059,723 | Jun 30, 2024 |
STATE OF ALASKA, DEPARTMENT OF REVENUE | 0.00% | 0.01% | 4,275 | 4,275 | 100.00% | 1,038,000 | Jun 30, 2024 |
MACHINA CAPITAL S.A.S. | 0.00% | 0.47% | 4,266 | 4,266 | 100.00% | 1,036,638 | Jun 30, 2024 |
SPECTRUM PLANNING & ADVISORY SERVICES INC. | 0.00% | 0.85% | 3,560 | 3,560 | 100.00% | 879,320 | Jun 30, 2024 |
CHOREO, LLC | 0.00% | 0.01% | 3,109 | 3,109 | 100.00% | 756,356 | Jun 30, 2024 |
HIGHVISTA STRATEGIES LLC | 0.00% | 0.23% | 2,602 | 2,602 | 100.00% | 632,286 | Jun 30, 2024 |
CREDIT AGRICOLE S A | 0.00% | 0.00% | 2,573 | 2,573 | 100.00% | 625,239 | Jun 30, 2024 |
COREBRIDGE FINANCIAL, INC. | 0.00% | 0.00% | 2,340 | 2,340 | 100.00% | 568,620 | Jun 30, 2024 |
QUANTINNO CAPITAL MANAGEMENT LP | 0.00% | 0.01% | 2,240 | 2,240 | 100.00% | 544,320 | Jun 30, 2024 |
PALLAS CAPITAL ADVISORS LLC | 0.00% | 0.02% | 2,052 | 2,052 | 100.00% | 485,708 | Jun 30, 2024 |
ALGERT GLOBAL LLC | 0.00% | 0.02% | 1,960 | 1,960 | 100.00% | 476,000 | Jun 30, 2024 |
GSA CAPITAL PARTNERS LLP | 0.00% | 0.03% | 1,842 | 1,842 | 100.00% | 448,000 | Jun 30, 2024 |
ATRIA INVESTMENTS, INC | 0.00% | 0.01% | 1,758 | 1,758 | 100.00% | 427,194 | Jun 30, 2024 |
UNITED CAPITAL FINANCIAL ADVISERS, LLC | 0.00% | 0.00% | 1,520 | 1,520 | 100.00% | 369,374 | Jun 30, 2024 |
COLONY GROUP, LLC | 0.00% | 0.00% | 1,493 | 1,493 | 100.00% | 363,000 | Jun 30, 2024 |
EVERHART FINANCIAL GROUP, INC. | 0.00% | 0.08% | 1,322 | 1,322 | 100.00% | 321,246 | Jun 30, 2024 |
EQIS CAPITAL MANAGEMENT, INC. | 0.00% | 0.03% | 1,285 | 1,285 | 100.00% | 312,303 | Jun 30, 2024 |
WEDMONT PRIVATE CAPITAL | 0.00% | 0.02% | 1,234 | 1,234 | 100.00% | 321,469 | Jun 30, 2024 |
DAI-ICHI LIFE INSURANCE COMPANY, LTD | 0.00% | 0.01% | 1,077 | 1,077 | 100.00% | 261,711 | Jun 30, 2024 |
BREAKWATER CAPITAL GROUP | 0.00% | 0.06% | 1,025 | 1,025 | 100.00% | 249,075 | Jun 30, 2024 |
FULTON BANK, N.A. | 0.00% | 0.01% | 1,018 | 1,018 | 100.00% | 247,374 | Jun 30, 2024 |
CENTIVA CAPITAL, LP | 0.00% | 0.00% | 1,000 | 1,000 | 100.00% | 243,000 | Jun 30, 2024 |
NJ STATE EMPLOYEES DEFERRED COMPENSATION PLAN | 0.00% | 0.03% | 1,000 | 1,000 | 100.00% | 243,000 | Jun 30, 2024 |
SUMMIT TRAIL ADVISORS, LLC | 0.00% | 0.01% | 929 | 929 | 100.00% | 225,747 | Jun 30, 2024 |
MERIT FINANCIAL GROUP, LLC | 0.00% | 0.01% | 928 | 928 | 100.00% | 225,504 | Jun 30, 2024 |
HCR WEALTH ADVISORS | 0.00% | 0.03% | 924 | 924 | 100.00% | 224,532 | Jun 30, 2024 |
FUKOKU MUTUAL LIFE INSURANCE CO | 0.00% | 0.02% | 914 | 914 | 100.00% | 222,102 | Jun 30, 2024 |
0.00% | 0.16% | 900 | 900 | 100.00% | 218,700 | Jun 30, 2024 | |
SYM FINANCIAL CORP | 0.00% | 0.03% | 892 | 892 | 100.00% | 216,756 | Jun 30, 2024 |
NWAM LLC | 0.00% | 0.06% | 852 | 852 | 100.00% | 207,036 | Jun 30, 2024 |
COLDSTREAM CAPITAL MANAGEMENT INC | 0.00% | 0.01% | 843 | 843 | 100.00% | 204,849 | Jun 30, 2024 |
CHAPIN DAVIS, INC. | 0.00% | 0.07% | 825 | 825 | 100.00% | 200,475 | Jun 30, 2024 |
PALOMA PARTNERS MANAGEMENT CO | 0.00% | 0.01% | 800 | 800 | 100.00% | 194,400 | Jun 30, 2024 |
CSS LLC/IL | 0.00% | 0.01% | 700 | 700 | 100.00% | 170,100 | Jun 30, 2024 |
CSS LLC/IL | 0.00% | 0.01% | 500 | 500 | 100.00% | 121,500 | Jun 30, 2024 |
CONCORD WEALTH PARTNERS | 0.00% | 0.01% | 200 | 200 | 100.00% | 48,600 | Jun 30, 2024 |
ASHTON THOMAS PRIVATE WEALTH, LLC | 0.00% | 0.00% | 108 | 108 | 100.00% | 26,244 | Jun 30, 2024 |
PALOMA PARTNERS MANAGEMENT CO | 0.00% | 0.00% | 100 | 100 | 100.00% | 24,300 | Jun 30, 2024 |
HARTFORD FINANCIAL MANAGEMENT INC. | 0.00% | 0.01% | 100 | 100 | 100.00% | 24,300 | Jun 30, 2024 |
NVERSES CAPITAL, LLC | 0.00% | 0.01% | 100 | 100 | 100.00% | 24,300 | Jun 30, 2024 |
UNIQUE WEALTH STRATEGIES, LLC | - | 0.00% | 23 | 23 | 100.00% | 3,437 | Jun 30, 2024 |
FINTRUST CAPITAL ADVISORS, LLC | - | 0.00% | 15 | 15 | 100.00% | 3,645 | Jun 30, 2024 |
HARBOR INVESTMENT ADVISORY, LLC | - | - | 1 | 1 | 100.00% | 243 | Jun 30, 2024 |
Alnylam Pharmaceuticals's largest new institutional shareholder by number of shares is NORGES BANK, purchased 2.30M shares, valued at $558.12M, as of undefined.
Institutional Sold Out
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
LOGOS GLOBAL MANAGEMENT LP | - | - | - | -500,000 | -100.00% | - | Jun 30, 2024 |
VESTAL POINT CAPITAL, LP | - | - | - | -350,000 | -100.00% | - | Jun 30, 2024 |
BALYASNY ASSET MANAGEMENT L.P. | - | - | - | -287,627 | -100.00% | - | Jun 30, 2024 |
ADAR1 CAPITAL MANAGEMENT, LLC | - | - | - | -234,400 | -100.00% | - | Jun 30, 2024 |
POINT72 ASSET MANAGEMENT, L.P. | - | - | - | -206,255 | -100.00% | - | Jun 30, 2024 |
PALO ALTO INVESTORS LP | - | - | - | -182,766 | -100.00% | - | Jun 30, 2024 |
QUBE RESEARCH & TECHNOLOGIES LTD | - | - | - | -110,759 | -100.00% | - | Jun 30, 2024 |
CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -90,234 | -100.00% | - | Jun 30, 2024 |
BARCLAYS PLC | - | - | - | -60,200 | -100.00% | - | Jun 30, 2024 |
IKARIAN CAPITAL, LLC | - | - | - | -51,541 | -100.00% | - | Jun 30, 2024 |
INTEGRAL HEALTH ASSET MANAGEMENT, LLC | - | - | - | -50,000 | -100.00% | - | Jun 30, 2024 |
HRT FINANCIAL LP | - | - | - | -41,927 | -100.00% | - | Jun 30, 2024 |
AFFINITY ASSET ADVISORS, LLC | - | - | - | -40,000 | -100.00% | - | Jun 30, 2024 |
PARNASSUS INVESTMENTS, LLC | - | - | - | -38,748 | -100.00% | - | Jun 30, 2024 |
MEDIOLANUM INTERNATIONAL FUNDS LTD | - | - | - | -38,556 | -100.00% | - | Jun 30, 2024 |
BANQUE PICTET & CIE SA | - | - | - | -33,005 | -100.00% | - | Jun 30, 2024 |
ROCK SPRINGS CAPITAL MANAGEMENT LP | - | - | - | -32,500 | -100.00% | - | Jun 30, 2024 |
HUDSON BAY CAPITAL MANAGEMENT LP | - | - | - | -30,000 | -100.00% | - | Jun 30, 2024 |
SEVEN EIGHT CAPITAL, LP | - | - | - | -25,809 | -100.00% | - | Jun 30, 2024 |
GOLDMAN SACHS GROUP INC | - | - | - | -25,000 | -100.00% | - | Jun 30, 2024 |
HAP TRADING, LLC | - | - | - | -23,798 | -100.00% | - | Jun 30, 2024 |
SPHERA FUNDS MANAGEMENT LTD. | - | - | - | -20,000 | -100.00% | - | Jun 30, 2024 |
SQUAREPOINT OPS LLC | - | - | - | -20,000 | -100.00% | - | Jun 30, 2024 |
EXODUSPOINT CAPITAL MANAGEMENT, LP | - | - | - | -18,658 | -100.00% | - | Jun 30, 2024 |
JUMP FINANCIAL, LLC | - | - | - | -17,554 | -100.00% | - | Jun 30, 2024 |
POINT72 HONG KONG LTD | - | - | - | -15,971 | -100.00% | - | Jun 30, 2024 |
TORNO CAPITAL, LLC | - | - | - | -15,000 | -100.00% | - | Jun 30, 2024 |
ROCKEFELLER CAPITAL MANAGEMENT L.P. | - | - | - | -10,715 | -100.00% | - | Jun 30, 2024 |
CAMPBELL & CO INVESTMENT ADVISER LLC | - | - | - | -10,614 | -100.00% | - | Jun 30, 2024 |
POINT72 (DIFC) LTD | - | - | - | -10,363 | -100.00% | - | Jun 30, 2024 |
DLD ASSET MANAGEMENT, LP | - | - | - | -10,000 | -100.00% | - | Jun 30, 2024 |
UBS GROUP AG | - | - | - | -10,000 | -100.00% | - | Jun 30, 2024 |
ALPHA DNA INVESTMENT MANAGEMENT LLC | - | - | - | -5,129 | -100.00% | - | Jun 30, 2024 |
MILLENNIUM MANAGEMENT LLC | - | - | - | -4,500 | -100.00% | - | Jun 30, 2024 |
STONERIDGE INVESTMENT PARTNERS LLC | - | - | - | -4,200 | -100.00% | - | Jun 30, 2024 |
TEZA CAPITAL MANAGEMENT LLC | - | - | - | -4,026 | -100.00% | - | Jun 30, 2024 |
HEADLANDS TECHNOLOGIES LLC | - | - | - | -3,150 | -100.00% | - | Jun 30, 2024 |
CORTON CAPITAL INC. | - | - | - | -3,004 | -100.00% | - | Jun 30, 2024 |
AQUILA INVESTMENT MANAGEMENT LLC | - | - | - | -3,000 | -100.00% | - | Jun 30, 2024 |
FOX RUN MANAGEMENT, L.L.C. | - | - | - | -2,988 | -100.00% | - | Jun 30, 2024 |
ALBERTA INVESTMENT MANAGEMENT CORP | - | - | - | -2,900 | -100.00% | - | Jun 30, 2024 |
TWIN TREE MANAGEMENT, LP | - | - | - | -2,900 | -100.00% | - | Jun 30, 2024 |
AIGEN INVESTMENT MANAGEMENT, LP | - | - | - | -2,827 | -100.00% | - | Jun 30, 2024 |
SCIENTECH RESEARCH LLC | - | - | - | -2,688 | -100.00% | - | Jun 30, 2024 |
PICTET & CIE (EUROPE) SA | - | - | - | -2,562 | -100.00% | - | Jun 30, 2024 |
ASAHI LIFE ASSET MANAGEMENT CO., LTD. | - | - | - | -2,150 | -100.00% | - | Jun 30, 2024 |
MOODY ALDRICH PARTNERS LLC | - | - | - | -2,138 | -100.00% | - | Jun 30, 2024 |
FARALLON CAPITAL MANAGEMENT LLC | - | - | - | -2,000 | -100.00% | - | Jun 30, 2024 |
AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -1,883 | -100.00% | - | Jun 30, 2024 |
ONTARIO TEACHERS PENSION PLAN BOARD | - | - | - | -1,833 | -100.00% | - | Jun 30, 2024 |
ENTRYPOINT CAPITAL, LLC | - | - | - | -1,724 | -100.00% | - | Jun 30, 2024 |
CANTOR FITZGERALD, L. P. | - | - | - | -1,584 | -100.00% | - | Jun 30, 2024 |
WINTON GROUP LTD | - | - | - | -1,471 | -100.00% | - | Jun 30, 2024 |
ABBREA CAPITAL, LLC | - | - | - | -1,425 | -100.00% | - | Jun 30, 2024 |
PEARL RIVER CAPITAL, LLC | - | - | - | -1,400 | -100.00% | - | Jun 30, 2024 |
WALLEYE CAPITAL LLC | - | - | - | -1,400 | -100.00% | - | Jun 30, 2024 |
STEVENS CAPITAL MANAGEMENT LP | - | - | - | -1,390 | -100.00% | - | Jun 30, 2024 |
OXFORD ASSET MANAGEMENT LLP | - | - | - | -1,344 | -100.00% | - | Jun 30, 2024 |
RIVERVIEW TRUST CO | - | - | - | -104 | -100.00% | - | Jun 30, 2024 |
ROYAL BANK OF CANADA | - | - | - | -100 | -100.00% | - | Jun 30, 2024 |
YHB INVESTMENT ADVISORS, INC. | - | - | - | -100 | -100.00% | - | Jun 30, 2024 |
MACROVIEW INVESTMENT MANAGEMENT LLC | - | - | - | -51 | -100.00% | - | Jun 30, 2024 |
COLONIAL TRUST ADVISORS | - | - | - | -9 | -100.00% | - | Jun 30, 2024 |
SOUTHSTATE CORP | - | - | - | -6 | -100.00% | - | Jun 30, 2024 |
DT INVESTMENT PARTNERS, LLC | - | - | - | -5 | -100.00% | - | Jun 30, 2024 |
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | - | - | - | -4 | -100.00% | - | Jun 30, 2024 |
CVA FAMILY OFFICE, LLC | - | - | - | -3 | -100.00% | - | Jun 30, 2024 |
- | - | - | -3 | -100.00% | - | Jun 30, 2024 | |
FINANCIAL GRAVITY ASSET MANAGEMENT, INC. | - | - | - | -1 | -100.00% | - | Jun 30, 2024 |
Alnylam Pharmaceuticals's largest sold out institutional shareholder by shares sold is LOGOS GLOBAL MANAGEMENT LP, sold -0.50M shares, valued at -, as of undefined.
Alnylam Pharmaceuticals Mutual Fund Holders
Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
---|---|---|---|---|---|
AMERICAN CENTURY GROWTH FUNDS, INC. | 1.21% | 188,760 | -24,198 | -11.36% | Jan 31, 2024 |
PUTNAM CONVERTIBLE SECURITIES FUND | 1.07% | 5,228,000 | - | - | Jan 31, 2024 |
Virtus Dividend, Interest & Premium Strategy Fund | 0.92% | 2,175,000 | - | - | Jan 31, 2024 |
Virtus Equity & Convertible Income Fund | 0.91% | 1,810,000 | - | - | Jan 31, 2024 |
CALAMOS STRATEGIC TOTAL RETURN FUND | 0.79% | 8,820,000 | - | - | Jan 31, 2024 |
Virtus Diversified Income & Convertible Fund | 0.77% | 1,565,000 | - | - | Jan 31, 2024 |
Virtus Artificial Intelligence & Technology Opportunities Fund | 0.76% | 3,000,000 | - | - | Jan 31, 2024 |
Virtus Artificial Intelligence & Technology Opportunities Fund | 0.76% | 3,000,000 | - | - | Jan 31, 2024 |
ADVENT CONVERTIBLE & INCOME FUND | 0.67% | 2,281,000 | - | - | Jan 31, 2024 |
Virtus Strategy Trust | 0.56% | 11,860,000 | - | - | Mar 28, 2024 |
Calamos Dynamic Convertible & Income Fund | 0.52% | 4,000,000 | - | - | Jan 31, 2024 |
Virtus Convertible & Income Fund II | 0.52% | 1,960,000 | - | - | Jan 31, 2024 |
Virtus Convertible & Income Fund | 0.50% | 2,485,000 | - | - | Jan 31, 2024 |
Milliman Variable Insurance Trust | 0.50% | 208 | -2 | -0.95% | Mar 31, 2024 |
FORUM FUNDS | 0.43% | 1,000,000 | - | - | Jan 31, 2024 |
FIDELITY FINANCIAL TRUST | 0.43% | 7,620,000 | - | - | Feb 29, 2024 |
HSBC FUNDS | 0.42% | 13,660 | - | - | Jan 31, 2024 |
T. Rowe Price Health Sciences Fund, Inc. | 0.41% | 1,359,507 | 183,881 | 15.64% | Mar 31, 2024 |
CALAMOS CONVERTIBLE & HIGH INCOME FUND | 0.40% | 5,000,000 | - | - | Jan 31, 2024 |
AMCAP FUND | 0.39% | 3,331,971 | 5,648 | 0.17% | Feb 29, 2024 |
CALAMOS CONVERTIBLE OPPORTUNITIES & INCOME FUND | 0.39% | 4,500,000 | - | - | Jan 31, 2024 |
Virtus Investment Trust | 0.36% | 12,410,000 | - | - | Mar 28, 2024 |
Virtus Investment Trust | 0.36% | 12,410,000 | - | - | Mar 28, 2024 |
GROWTH FUND OF AMERICA | 0.33% | 8,160,891 | 38,878 | 0.48% | Feb 29, 2024 |
Virtus Equity & Convertible Income Fund | 0.31% | 615,000 | 615,000 | - | Jan 31, 2024 |
Capital Group Growth ETF | 0.31% | 119,641 | 15,186 | 14.54% | Feb 29, 2024 |
Virtus Dividend, Interest & Premium Strategy Fund | 0.31% | 725,000 | 725,000 | - | Jan 31, 2024 |
CALAMOS INVESTMENT TRUST/IL | 0.30% | 31,545,000 | - | - | Jan 31, 2024 |
NEW ECONOMY FUND | 0.28% | 1,269,690 | -193,240 | -13.21% | Feb 29, 2024 |
T. Rowe Price New Horizons Fund, Inc. | 0.26% | 1,324,945 | -52,287 | -3.80% | Mar 31, 2024 |
Virtus Diversified Income & Convertible Fund | 0.26% | 535,000 | 535,000 | - | Jan 31, 2024 |
Ultimus Managers Trust | 0.26% | 3,000,000 | - | - | Feb 29, 2024 |
Tema ETF Trust | 0.21% | 9,355 | 7,052 | 306.21% | Feb 29, 2024 |
Capital Group U.S. Equity Fund | 0.18% | 6,279 | 1,248 | 24.81% | Jan 31, 2024 |
Virtus Convertible & Income Fund II | 0.18% | 665,000 | 665,000 | - | Jan 31, 2024 |
Virtus Convertible & Income Fund | 0.17% | 845,000 | 845,000 | - | Jan 31, 2024 |
AIM GROWTH SERIES (INVESCO GROWTH SERIES) | 0.17% | 5,270,000 | - | - | Mar 31, 2024 |
MFS SERIES TRUST II | 0.17% | 527,419 | - | - | Feb 29, 2024 |
T. Rowe Price Diversified Mid-Cap Growth Fund, Inc. | 0.16% | 54,780 | -2,000 | -3.52% | Mar 31, 2024 |
ELLSWORTH GROWTH & INCOME FUND LTD | 0.16% | 220,000 | - | - | Dec 29, 2023 |
GABELLI CONVERTIBLE & INCOME SECURITIES FUND INC | 0.15% | 120,000 | - | - | Dec 29, 2023 |
AIM COUNSELOR SERIES TRUST (INVESCO COUNSELOR SERIES TRUST) | 0.15% | 35,337,000 | - | - | Feb 29, 2024 |
PIONEER SERIES TRUST XI | 0.15% | 73,034 | - | - | Mar 28, 2024 |
UBS RELATIONSHIP FUNDS | 0.14% | 33,352 | - | - | Jun 30, 2020 |
JP MORGAN MUTUAL FUND INVESTMENT TRUST | 0.14% | 523,468 | -519 | -0.10% | Dec 31, 2023 |
TEKLA HEALTHCARE INVESTORS | 0.13% | 113,894 | -10,693 | -8.58% | Mar 31, 2024 |
TEKLA LIFE SCIENCES INVESTORS | 0.13% | 60,121 | -3,062 | -4.85% | Mar 31, 2024 |
BANCROFT FUND LTD | 0.12% | 160,000 | - | - | Dec 29, 2023 |
VANGUARD VALLEY FORGE FUNDS | 0.11% | 55,023 | 170 | 0.31% | Mar 31, 2024 |
VANGUARD SPECIALIZED FUNDS | 0.10% | 5,524,903 | - | - | Jan 31, 2024 |
BlackRock Health Sciences Trust | 0.10% | 24,255 | 11,245 | 86.43% | Mar 31, 2024 |
CALAMOS GLOBAL TOTAL RETURN FUND | 0.10% | 221,000 | - | - | Jan 31, 2024 |
T. Rowe Price Mid-Cap Growth Fund, Inc. | 0.09% | 1,398,000 | -272,800 | -16.33% | Mar 31, 2024 |
Voya VARIABLE PRODUCTS TRUST | 0.09% | 32,654 | - | - | Mar 31, 2024 |
PIONEER SERIES TRUST XII | 0.09% | 65,448 | -4,161 | -5.98% | Feb 29, 2024 |
Calamos Global Dynamic Income Fund | 0.08% | 969,000 | - | - | Jan 31, 2024 |
BNY MELLON RESEARCH GROWTH FUND, INC. | 0.08% | 46,447 | 46,447 | - | Feb 29, 2024 |
NEW PERSPECTIVE FUND | 0.08% | 2,409,705 | -908,976 | -27.39% | Mar 31, 2024 |
BlackRock Health Sciences Trust II | 0.08% | 208,667 | 105,700 | 102.65% | Mar 31, 2024 |
FIDELITY MT VERNON STREET TRUST | 0.08% | 2,229,905 | -407,033 | -15.44% | Feb 29, 2024 |
FIDELITY ADVISOR SERIES VII | 0.07% | 576,486 | 235,000 | 68.82% | Jan 31, 2024 |
AMERICAN FUNDS FUNDAMENTAL INVESTORS | 0.07% | 1,364,643 | -1,261,621 | -48.04% | Mar 31, 2024 |
LORD ABBETT SECURITIES TRUST | 0.06% | 297,712 | - | - | Jan 31, 2024 |
Humankind Benefit Corp | 0.06% | 1,270 | 128 | 11.21% | Dec 31, 2023 |
T. Rowe Price Equity Series, Inc. | 0.05% | 89,986 | 4,137 | 4.82% | Mar 31, 2024 |
LAUDUS TRUST | 0.05% | 26,470 | 18,582 | 235.57% | Mar 31, 2024 |
MFS SERIES TRUST IV | 0.05% | 167,327 | - | - | Feb 29, 2024 |
MAINSTAY VP FUNDS TRUST | 0.05% | 5,744,000 | - | - | Mar 31, 2024 |
Voya PARTNERS INC | 0.04% | 3,300,000 | - | - | Mar 31, 2024 |
Voya PARTNERS INC | 0.04% | 3,300,000 | - | - | Mar 31, 2024 |
PUTNAM GLOBAL HEALTH CARE FUND | 0.04% | 65,500 | - | - | Feb 29, 2024 |
Cushing Mutual Funds Trust | 0.04% | 1,133 | - | - | Aug 31, 2023 |
Natixis ETF Trust II | 0.03% | 563 | - | - | Mar 31, 2024 |
HARBOR FUNDS | 0.03% | 692,000 | - | - | Jan 31, 2024 |
Engine No. 1 ETF Trust | 0.03% | 1,753 | -91 | -4.93% | Jan 31, 2024 |
VARIABLE INSURANCE PRODUCTS FUND IV | 0.03% | 70,500 | 18,500 | 35.58% | Mar 31, 2024 |
PARNASSUS FUNDS | 0.03% | 38,748 | - | - | Mar 31, 2024 |
DELAWARE GROUP EQUITY FUNDS IV | 0.03% | 30,000 | -11,079 | -26.97% | Mar 28, 2024 |
VANGUARD INDEX FUNDS | 0.03% | 10,697,198 | -1,847,728 | -14.73% | Mar 31, 2024 |
T. Rowe Price Tax-Efficient Funds, Inc. | 0.02% | 2,301 | - | - | Feb 29, 2024 |
MAINSTAY FUNDS | 0.02% | 5,460,000 | - | - | Jan 31, 2024 |
FIDELITY SECURITIES FUND | 0.02% | 2,068,831 | -29,027 | -1.38% | Jan 31, 2024 |
REYNOLDS FUNDS INC | 0.02% | 250 | - | - | Mar 31, 2024 |
LORD ABBETT RESEARCH FUND INC | 0.02% | 21,264 | - | - | Feb 29, 2024 |
T. Rowe Price Equity Funds, Inc. | 0.02% | 240,822 | -63,478 | -20.86% | Mar 31, 2024 |
FIDELITY DESTINY PORTFOLIOS | 0.02% | 47,600 | 4,600 | 10.70% | Mar 31, 2024 |
TOCQUEVILLE TRUST | 0.02% | 3,000 | - | - | Jan 31, 2024 |
FIRST TRUST EXCHANGE-TRADED FUND | 0.02% | 203,519 | -36,292 | -15.13% | Mar 31, 2024 |
FIDELITY CAPITAL TRUST | 0.02% | 208,500 | 11,400 | 5.78% | Jan 31, 2024 |
AMERICAN CENTURY MUTUAL FUNDS, INC. | 0.02% | 183,000 | -89,876 | -32.94% | Jan 31, 2024 |
Advantage Advisers Xanthus Fund, L.L.C. | 0.02% | 53,694 | - | - | Mar 31, 2024 |
FIDELITY SELECT PORTFOLIOS | 0.02% | 1,093,553 | 292,600 | 36.53% | Feb 29, 2024 |
Calvert Responsible Index Series, Inc. | 0.02% | 26,406 | - | - | Mar 31, 2024 |
Capital Group Global Growth Equity ETF | 0.02% | 18,264 | - | - | Feb 29, 2024 |
VARIABLE INSURANCE PRODUCTS FUND | 0.02% | 326,424 | 3,300 | 1.02% | Mar 31, 2024 |
FRANKLIN STRATEGIC SERIES | 0.01% | 126,200 | - | - | Jan 31, 2024 |
Voya EQUITY TRUST | 0.01% | 21,170 | - | - | Feb 29, 2024 |
JNL VARIABLE FUND LLC | 0.01% | 80,997 | -3,198 | -3.80% | Mar 31, 2020 |
TIAA SEPARATE ACCOUNT VA 1 | 0.01% | 3,180 | - | - | Mar 31, 2024 |
LORD ABBETT INVESTMENT TRUST | 0.01% | 13,677,000 | - | - | Feb 29, 2024 |
Alnylam Pharmaceuticals's largest mutual fund holder by % of total assets is "AMERICAN CENTURY GROWTH FUNDS, INC.", owning 188.76K shares, compromising 1.21% of its total assets.
Alnylam Pharmaceuticals Institutional Ownership Trends
Institutional Holdings Trend
Date | Holdings | Change % |
---|---|---|
30 Jun, 24 | 560 | 1.27% |
31 Mar, 24 | 553 | 3.56% |
31 Dec, 23 | 534 | 8.32% |
30 Sep, 23 | 493 | 0.61% |
30 Jun, 23 | 490 | -1.01% |
31 Mar, 23 | 495 | -3.32% |
31 Dec, 22 | 512 | -0.39% |
30 Sep, 22 | 514 | 13.72% |
30 Jun, 22 | 452 | -2.38% |
31 Mar, 22 | 463 | 1.31% |
31 Dec, 21 | 457 | 8.04% |
30 Sep, 21 | 423 | -3.64% |
30 Jun, 21 | 439 | 7.33% |
31 Mar, 21 | 409 | 2.25% |
31 Dec, 20 | 400 | 4.17% |
30 Sep, 20 | 384 | -3.27% |
30 Jun, 20 | 397 | 10.58% |
31 Mar, 20 | 359 | 4.36% |
31 Dec, 19 | 344 | 11.33% |
30 Sep, 19 | 309 | -1.28% |
30 Jun, 19 | 313 | -0.32% |
31 Mar, 19 | 314 | 2.28% |
31 Dec, 18 | 307 | -10.50% |
30 Sep, 18 | 343 | 2.08% |
30 Jun, 18 | 336 | 4.35% |
31 Mar, 18 | 322 | 4.21% |
31 Dec, 17 | 309 | 11.96% |
30 Sep, 17 | 276 | 10.84% |
30 Jun, 17 | 249 | 10.67% |
31 Mar, 17 | 225 | -2.17% |
31 Dec, 16 | 230 | -18.73% |
30 Sep, 16 | 283 | 4.81% |
30 Jun, 16 | 270 | -2.17% |
31 Mar, 16 | 276 | 1.10% |
31 Dec, 15 | 273 | -0.36% |
30 Sep, 15 | 274 | -7.12% |
30 Jun, 15 | 295 | 15.69% |
31 Mar, 15 | 255 | 11.35% |
31 Dec, 14 | 229 | 15.66% |
30 Sep, 14 | 198 | -6.16% |
30 Jun, 14 | 211 | -2.76% |
31 Mar, 14 | 217 | 19.89% |
31 Dec, 13 | 181 | -0.55% |
30 Sep, 13 | 182 | 21.33% |
30 Jun, 13 | 150 | 154.24% |
31 Mar, 13 | 59 | 34.09% |
31 Dec, 12 | 44 | -20.00% |
30 Sep, 12 | 55 | 25.00% |
30 Jun, 12 | 44 | -6.38% |
31 Mar, 12 | 47 | 20.51% |
31 Dec, 11 | 39 | 25.81% |
30 Sep, 11 | 31 | - |
30 Jun, 11 | 31 | -3.13% |
31 Mar, 11 | 32 | 3.23% |
31 Dec, 10 | 31 | 34.78% |
30 Sep, 10 | 23 | -8.00% |
30 Jun, 10 | 25 | 19.05% |
31 Mar, 10 | 21 | -4.55% |
31 Dec, 09 | 22 | -18.52% |
30 Sep, 09 | 27 | -22.86% |
30 Jun, 09 | 35 | 9.38% |
31 Mar, 09 | 32 | -13.51% |
31 Dec, 08 | 37 | 27.59% |
30 Sep, 08 | 29 | 7.41% |
30 Jun, 08 | 27 | -10.00% |
31 Mar, 08 | 30 | -3.23% |
31 Dec, 07 | 31 | 40.91% |
30 Sep, 07 | 22 | -15.38% |
30 Jun, 07 | 26 | 4.00% |
31 Mar, 07 | 25 | 4.17% |
31 Dec, 06 | 24 | 9.09% |
30 Sep, 06 | 22 | 37.50% |
30 Jun, 06 | 16 | 14.29% |
31 Mar, 06 | 14 | 100.00% |
31 Dec, 05 | 7 | -12.50% |
30 Sep, 05 | 8 | 166.67% |
30 Jun, 05 | 3 | -25.00% |
31 Mar, 05 | 4 | 33.33% |
31 Dec, 04 | 3 | 200.00% |
30 Sep, 04 | 1 | - |
30 Jun, 04 | 1 | - |
As of 30 Jun 24, 560 institutions are holding Alnylam Pharmaceuticals's shares, representing an increase of 1.27% compared to the previous quarter.
Shares Outstanding Trend
Date | Shares Outstanding | Change % |
---|---|---|
30 Jun, 24 | 119,859,699 | 6.53% |
31 Mar, 24 | 112,509,382 | -3.80% |
31 Dec, 23 | 116,949,479 | 0.55% |
30 Sep, 23 | 116,310,429 | -1.58% |
30 Jun, 23 | 118,175,400 | -0.98% |
31 Mar, 23 | 119,339,488 | -0.11% |
31 Dec, 22 | 119,469,955 | -10.10% |
30 Sep, 22 | 132,884,745 | 17.62% |
30 Jun, 22 | 112,981,167 | -0.42% |
31 Mar, 22 | 113,456,228 | 1.74% |
31 Dec, 21 | 111,519,696 | 0.37% |
30 Sep, 21 | 111,104,698 | -0.64% |
30 Jun, 21 | 111,817,068 | 2.64% |
31 Mar, 21 | 108,937,688 | 0.97% |
31 Dec, 20 | 107,886,144 | -0.40% |
30 Sep, 20 | 108,319,172 | -2.80% |
30 Jun, 20 | 111,436,124 | 2.92% |
31 Mar, 20 | 108,277,553 | 2.42% |
31 Dec, 19 | 105,718,192 | -2.06% |
30 Sep, 19 | 107,943,373 | 1.85% |
30 Jun, 19 | 105,982,622 | 9.50% |
31 Mar, 19 | 96,786,567 | 4.73% |
31 Dec, 18 | 92,415,190 | 1.95% |
30 Sep, 18 | 90,651,136 | -0.94% |
30 Jun, 18 | 91,515,814 | -0.14% |
31 Mar, 18 | 91,640,033 | -0.57% |
31 Dec, 17 | 92,168,593 | 5.31% |
30 Sep, 17 | 87,520,466 | 0.35% |
30 Jun, 17 | 87,213,397 | 5.97% |
31 Mar, 17 | 82,298,894 | 2.97% |
31 Dec, 16 | 79,928,117 | 3.07% |
30 Sep, 16 | 77,546,983 | 4.63% |
30 Jun, 16 | 74,115,161 | 2.82% |
31 Mar, 16 | 72,084,599 | 9.15% |
31 Dec, 15 | 66,043,326 | -14.28% |
30 Sep, 15 | 77,043,364 | 17.50% |
30 Jun, 15 | 65,567,282 | 1.69% |
31 Mar, 15 | 64,475,420 | 11.14% |
31 Dec, 14 | 58,012,605 | -1.64% |
30 Sep, 14 | 58,982,649 | 2.07% |
30 Jun, 14 | 57,784,900 | 3.73% |
31 Mar, 14 | 55,705,226 | 0.73% |
31 Dec, 13 | 55,301,194 | 7.94% |
30 Sep, 13 | 51,233,407 | 10.19% |
30 Jun, 13 | 46,496,933 | 97.84% |
31 Mar, 13 | 23,502,732 | 39.39% |
31 Dec, 12 | 16,861,031 | 5.78% |
30 Sep, 12 | 15,939,542 | -12.16% |
30 Jun, 12 | 18,146,235 | -9.37% |
31 Mar, 12 | 20,022,783 | 62.30% |
31 Dec, 11 | 12,336,694 | 7.12% |
30 Sep, 11 | 11,516,326 | -14.30% |
30 Jun, 11 | 13,437,262 | 83.04% |
31 Mar, 11 | 7,341,131 | 34.06% |
31 Dec, 10 | 5,475,993 | 85.01% |
30 Sep, 10 | 2,959,763 | -9.18% |
30 Jun, 10 | 3,258,845 | -23.89% |
31 Mar, 10 | 4,281,801 | 21.55% |
31 Dec, 09 | 3,522,595 | -4.62% |
30 Sep, 09 | 3,693,347 | 15.21% |
30 Jun, 09 | 3,205,857 | -65.73% |
31 Mar, 09 | 9,354,874 | -27.95% |
31 Dec, 08 | 12,983,088 | 262.33% |
30 Sep, 08 | 3,583,262 | 6.43% |
30 Jun, 08 | 3,366,795 | -1.57% |
31 Mar, 08 | 3,420,618 | -59.04% |
31 Dec, 07 | 8,351,692 | 0.84% |
30 Sep, 07 | 8,282,366 | -15.77% |
30 Jun, 07 | 9,833,574 | 125.52% |
31 Mar, 07 | 4,360,486 | -53.54% |
31 Dec, 06 | 9,386,143 | 10.86% |
30 Sep, 06 | 8,466,374 | 37.12% |
30 Jun, 06 | 6,174,506 | 112.92% |
31 Mar, 06 | 2,899,862 | 307.93% |
31 Dec, 05 | 710,870 | -79.66% |
30 Sep, 05 | 3,494,690 | 853.34% |
30 Jun, 05 | 366,572 | 68.14% |
31 Mar, 05 | 218,017 | -83.89% |
31 Dec, 04 | 1,353,710 | 19.78% |
30 Sep, 04 | 1,130,200 | -13.01% |
30 Jun, 04 | 1,299,293 | - |
Alnylam Pharmaceuticals (ALNY) has 119.86M shares outstanding as of 30 Jun 24, up 6.53% compared to the previous quarter.
Institutional Ownership Trend
Date | Ownership % | Change % |
---|---|---|
30 Jun, 24 | 95.02% | 1.19% |
31 Mar, 24 | 89.20% | 1.02% |
31 Dec, 23 | 93.63% | 1.09% |
30 Sep, 23 | 92.88% | 1.03% |
30 Jun, 23 | 94.80% | 1.03% |
31 Mar, 23 | 96.16% | 1.00% |
31 Dec, 22 | 98.18% | 0.83% |
30 Sep, 22 | 108.77% | 1.25% |
30 Jun, 22 | 93.45% | 1.05% |
31 Mar, 22 | 94.41% | 1.09% |
31 Dec, 21 | 93.11% | 1.07% |
30 Sep, 21 | 93.44% | 1.04% |
30 Jun, 21 | 94.94% | 1.10% |
31 Mar, 21 | 93.05% | 1.06% |
31 Dec, 20 | 93.83% | 1.08% |
30 Sep, 20 | 93.39% | 0.99% |
30 Jun, 20 | 96.98% | 1.05% |
31 Mar, 20 | 96.03% | 1.03% |
31 Dec, 19 | 96.75% | 0.98% |
30 Sep, 19 | 99.30% | 1.04% |
30 Jun, 19 | 97.61% | 1.16% |
31 Mar, 19 | 91.83% | 1.10% |
31 Dec, 18 | 91.44% | 1.13% |
30 Sep, 18 | 89.95% | 1.09% |
30 Jun, 18 | 91.04% | 1.08% |
31 Mar, 18 | 91.66% | 1.00% |
31 Dec, 17 | 95.87% | 1.06% |
30 Sep, 17 | 95.31% | 0.97% |
30 Jun, 17 | 99.00% | 1.08% |
31 Mar, 17 | 95.67% | 1.10% |
31 Dec, 16 | 93.38% | 1.14% |
30 Sep, 16 | 90.47% | 1.21% |
30 Jun, 16 | 86.64% | 1.21% |
31 Mar, 16 | 84.53% | 1.37% |
31 Dec, 15 | 78.63% | 0.95% |
30 Sep, 15 | 91.03% | 1.51% |
30 Jun, 15 | 77.73% | 1.26% |
31 Mar, 15 | 78.56% | 1.29% |
31 Dec, 14 | 78.10% | 1.31% |
30 Sep, 14 | 77.19% | 1.33% |
30 Jun, 14 | 76.20% | 1.13% |
31 Mar, 14 | 82.18% | 1.06% |
31 Dec, 13 | 87.91% | 1.30% |
30 Sep, 13 | 82.08% | 1.44% |
30 Jun, 13 | 75.41% | 4.78% |
31 Mar, 13 | 39.72% | 3.75% |
31 Dec, 12 | 32.54% | 3.40% |
30 Sep, 12 | 30.93% | 2.47% |
30 Jun, 12 | 35.39% | 1.88% |
31 Mar, 12 | 43.33% | 5.12% |
31 Dec, 11 | 29.09% | 3.99% |
30 Sep, 11 | 27.00% | 2.69% |
30 Jun, 11 | 31.71% | 10.55% |
31 Mar, 11 | 17.34% | 10.22% |
31 Dec, 10 | 13.03% | 26.38% |
30 Sep, 10 | 7.03% | 11.67% |
30 Jun, 10 | 7.76% | 7.42% |
31 Mar, 10 | 10.23% | 14.45% |
31 Dec, 09 | 8.41% | 10.73% |
30 Sep, 09 | 8.86% | 14.85% |
30 Jun, 09 | 7.72% | 1.51% |
31 Mar, 09 | 22.60% | 2.26% |
31 Dec, 08 | 31.61% | 41.78% |
30 Sep, 08 | 8.70% | 12.84% |
30 Jun, 08 | 8.23% | 11.67% |
31 Mar, 08 | 8.40% | 1.99% |
31 Dec, 07 | 20.53% | 4.56% |
30 Sep, 07 | 21.22% | 3.09% |
30 Jun, 07 | 26.20% | 19.25% |
31 Mar, 07 | 11.67% | 1.85% |
31 Dec, 06 | 25.11% | 3.61% |
30 Sep, 06 | 26.36% | 7.08% |
30 Jun, 06 | 19.29% | 20.68% |
31 Mar, 06 | 9.66% | 92.07% |
31 Dec, 05 | 3.24% | 1.16% |
30 Sep, 05 | 16.71% | 528.00% |
30 Jun, 05 | 1.78% | 156.29% |
31 Mar, 05 | 1.07% | 2.43% |
31 Dec, 04 | 6.62% | 21.66% |
30 Sep, 04 | 5.53% | 1.60% |
30 Jun, 04 | 18.57% | - |
As of 30 Jun 24, Alnylam Pharmaceuticals is held by 95.02% institutional shareholders, representing a 1.19% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
Date | Increased Positions | Change % |
---|---|---|
30 Jun, 24 | 281 | 2.55% |
31 Mar, 24 | 274 | 3.40% |
31 Dec, 23 | 265 | 28.02% |
30 Sep, 23 | 207 | -2.82% |
30 Jun, 23 | 213 | -6.17% |
31 Mar, 23 | 227 | -9.92% |
31 Dec, 22 | 252 | -11.27% |
30 Sep, 22 | 284 | 51.87% |
30 Jun, 22 | 187 | -16.89% |
31 Mar, 22 | 225 | -3.85% |
31 Dec, 21 | 234 | 14.71% |
30 Sep, 21 | 204 | 4.08% |
30 Jun, 21 | 196 | -2.97% |
31 Mar, 21 | 202 | 16.76% |
31 Dec, 20 | 173 | 10.19% |
30 Sep, 20 | 157 | -25.24% |
30 Jun, 20 | 210 | 21.39% |
31 Mar, 20 | 173 | - |
31 Dec, 19 | 173 | 20.98% |
30 Sep, 19 | 143 | -7.14% |
30 Jun, 19 | 154 | 0.65% |
31 Mar, 19 | 153 | 10.87% |
31 Dec, 18 | 138 | -10.39% |
30 Sep, 18 | 154 | -13.48% |
30 Jun, 18 | 178 | 7.23% |
31 Mar, 18 | 166 | -4.60% |
31 Dec, 17 | 174 | 45.00% |
30 Sep, 17 | 120 | -8.40% |
30 Jun, 17 | 131 | 32.32% |
31 Mar, 17 | 99 | -10.81% |
31 Dec, 16 | 111 | -3.48% |
30 Sep, 16 | 115 | -20.69% |
30 Jun, 16 | 145 | -2.03% |
31 Mar, 16 | 148 | 5.71% |
31 Dec, 15 | 140 | 6.87% |
30 Sep, 15 | 131 | -24.28% |
30 Jun, 15 | 173 | 14.57% |
31 Mar, 15 | 151 | 39.81% |
31 Dec, 14 | 108 | 30.12% |
30 Sep, 14 | 83 | -18.63% |
30 Jun, 14 | 102 | -12.82% |
31 Mar, 14 | 117 | 32.95% |
31 Dec, 13 | 88 | -16.98% |
30 Sep, 13 | 106 | -4.50% |
30 Jun, 13 | 111 | 164.29% |
31 Mar, 13 | 42 | 75.00% |
31 Dec, 12 | 24 | -29.41% |
30 Sep, 12 | 34 | 36.00% |
30 Jun, 12 | 25 | -26.47% |
31 Mar, 12 | 34 | 30.77% |
31 Dec, 11 | 26 | 62.50% |
30 Sep, 11 | 16 | - |
30 Jun, 11 | 16 | - |
31 Mar, 11 | 16 | -23.81% |
31 Dec, 10 | 21 | 133.33% |
30 Sep, 10 | 9 | -25.00% |
30 Jun, 10 | 12 | 20.00% |
31 Mar, 10 | 10 | - |
31 Dec, 09 | 10 | -16.67% |
30 Sep, 09 | 12 | -42.86% |
30 Jun, 09 | 21 | -16.00% |
31 Mar, 09 | 25 | -16.67% |
31 Dec, 08 | 30 | 87.50% |
30 Sep, 08 | 16 | -11.11% |
30 Jun, 08 | 18 | -5.26% |
31 Mar, 08 | 19 | 5.56% |
31 Dec, 07 | 18 | 157.14% |
30 Sep, 07 | 7 | -50.00% |
30 Jun, 07 | 14 | -26.32% |
31 Mar, 07 | 19 | 18.75% |
31 Dec, 06 | 16 | - |
30 Sep, 06 | 16 | 33.33% |
30 Jun, 06 | 12 | 20.00% |
31 Mar, 06 | 10 | 100.00% |
31 Dec, 05 | 5 | -28.57% |
30 Sep, 05 | 7 | 133.33% |
30 Jun, 05 | 3 | 200.00% |
31 Mar, 05 | 1 | -66.67% |
31 Dec, 04 | 3 | - |
30 Sep, 04 | - | -100.00% |
30 Jun, 04 | 1 | - |
281 institutional shareholders have increased their position in ALNY stock as of 30 Jun 24 compared to 274 in the previous quarter (a 2.55% increase).
Institutional Reduced Positions Trend
Date | Reduced Positions | Change % |
---|---|---|
30 Jun, 24 | 160 | 1.91% |
31 Mar, 24 | 157 | 1.95% |
31 Dec, 23 | 154 | -7.23% |
30 Sep, 23 | 166 | 7.79% |
30 Jun, 23 | 154 | -8.33% |
31 Mar, 23 | 168 | 10.53% |
31 Dec, 22 | 152 | 1.33% |
30 Sep, 22 | 150 | -8.54% |
30 Jun, 22 | 164 | 15.49% |
31 Mar, 22 | 142 | 11.81% |
31 Dec, 21 | 127 | 6.72% |
30 Sep, 21 | 119 | -9.85% |
30 Jun, 21 | 132 | 12.82% |
31 Mar, 21 | 117 | -6.40% |
31 Dec, 20 | 125 | -0.79% |
30 Sep, 20 | 126 | 13.51% |
30 Jun, 20 | 111 | 11.00% |
31 Mar, 20 | 100 | 5.26% |
31 Dec, 19 | 95 | 23.38% |
30 Sep, 19 | 77 | - |
30 Jun, 19 | 77 | -11.49% |
31 Mar, 19 | 87 | -12.12% |
31 Dec, 18 | 99 | 6.45% |
30 Sep, 18 | 93 | 13.41% |
30 Jun, 18 | 82 | -6.82% |
31 Mar, 18 | 88 | 22.22% |
31 Dec, 17 | 72 | -14.29% |
30 Sep, 17 | 84 | 29.23% |
30 Jun, 17 | 65 | -8.45% |
31 Mar, 17 | 71 | -1.39% |
31 Dec, 16 | 72 | -18.18% |
30 Sep, 16 | 88 | 41.94% |
30 Jun, 16 | 62 | -1.59% |
31 Mar, 16 | 63 | -17.11% |
31 Dec, 15 | 76 | -12.64% |
30 Sep, 15 | 87 | 6.10% |
30 Jun, 15 | 82 | 32.26% |
31 Mar, 15 | 62 | -27.91% |
31 Dec, 14 | 86 | 28.36% |
30 Sep, 14 | 67 | -8.22% |
30 Jun, 14 | 73 | 15.87% |
31 Mar, 14 | 63 | -7.35% |
31 Dec, 13 | 68 | 28.30% |
30 Sep, 13 | 53 | 112.00% |
30 Jun, 13 | 25 | 212.50% |
31 Mar, 13 | 8 | -27.27% |
31 Dec, 12 | 11 | -8.33% |
30 Sep, 12 | 12 | 20.00% |
30 Jun, 12 | 10 | 66.67% |
31 Mar, 12 | 6 | -14.29% |
31 Dec, 11 | 7 | - |
30 Sep, 11 | 7 | -22.22% |
30 Jun, 11 | 9 | 12.50% |
31 Mar, 11 | 8 | 300.00% |
31 Dec, 10 | 2 | -66.67% |
30 Sep, 10 | 6 | -14.29% |
30 Jun, 10 | 7 | 16.67% |
31 Mar, 10 | 6 | 20.00% |
31 Dec, 09 | 5 | -16.67% |
30 Sep, 09 | 6 | -33.33% |
30 Jun, 09 | 9 | 80.00% |
31 Mar, 09 | 5 | - |
31 Dec, 08 | 5 | -50.00% |
30 Sep, 08 | 10 | 100.00% |
30 Jun, 08 | 5 | -28.57% |
31 Mar, 08 | 7 | - |
31 Dec, 07 | 7 | -30.00% |
30 Sep, 07 | 10 | 66.67% |
30 Jun, 07 | 6 | 50.00% |
31 Mar, 07 | 4 | - |
31 Dec, 06 | 4 | 300.00% |
30 Sep, 06 | 1 | - |
30 Jun, 06 | - | -100.00% |
31 Mar, 06 | 2 | 100.00% |
31 Dec, 05 | 1 | - |
30 Sep, 05 | 1 | - |
30 Jun, 05 | - | -100.00% |
31 Mar, 05 | 2 | - |
31 Dec, 04 | - | -100.00% |
30 Sep, 04 | 1 | - |
30 Jun, 04 | - | - |
160 institutional shareholders have reduced their position in ALNY stock as of 30 Jun 24 compared to 157 in the previous quarter (a 1.91% increase).
All Institutional Ownership Trend Data
Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
---|---|---|---|---|---|---|---|---|---|---|
30 Jun, 24 | 560 | 1.27% | 119,859,699 | 6.53% | 95.02% | 1.19% | 281 | 2.55% | 160 | 1.91% |
31 Mar, 24 | 553 | 3.56% | 112,509,382 | -3.80% | 89.20% | 1.02% | 274 | 3.40% | 157 | 1.95% |
31 Dec, 23 | 534 | 8.32% | 116,949,479 | 0.55% | 93.63% | 1.09% | 265 | 28.02% | 154 | -7.23% |
30 Sep, 23 | 493 | 0.61% | 116,310,429 | -1.58% | 92.88% | 1.03% | 207 | -2.82% | 166 | 7.79% |
30 Jun, 23 | 490 | -1.01% | 118,175,400 | -0.98% | 94.80% | 1.03% | 213 | -6.17% | 154 | -8.33% |
31 Mar, 23 | 495 | -3.32% | 119,339,488 | -0.11% | 96.16% | 1.00% | 227 | -9.92% | 168 | 10.53% |
31 Dec, 22 | 512 | -0.39% | 119,469,955 | -10.10% | 98.18% | 0.83% | 252 | -11.27% | 152 | 1.33% |
30 Sep, 22 | 514 | 13.72% | 132,884,745 | 17.62% | 108.77% | 1.25% | 284 | 51.87% | 150 | -8.54% |
30 Jun, 22 | 452 | -2.38% | 112,981,167 | -0.42% | 93.45% | 1.05% | 187 | -16.89% | 164 | 15.49% |
31 Mar, 22 | 463 | 1.31% | 113,456,228 | 1.74% | 94.41% | 1.09% | 225 | -3.85% | 142 | 11.81% |
31 Dec, 21 | 457 | 8.04% | 111,519,696 | 0.37% | 93.11% | 1.07% | 234 | 14.71% | 127 | 6.72% |
30 Sep, 21 | 423 | -3.64% | 111,104,698 | -0.64% | 93.44% | 1.04% | 204 | 4.08% | 119 | -9.85% |
30 Jun, 21 | 439 | 7.33% | 111,817,068 | 2.64% | 94.94% | 1.10% | 196 | -2.97% | 132 | 12.82% |
31 Mar, 21 | 409 | 2.25% | 108,937,688 | 0.97% | 93.05% | 1.06% | 202 | 16.76% | 117 | -6.40% |
31 Dec, 20 | 400 | 4.17% | 107,886,144 | -0.40% | 93.83% | 1.08% | 173 | 10.19% | 125 | -0.79% |
30 Sep, 20 | 384 | -3.27% | 108,319,172 | -2.80% | 93.39% | 0.99% | 157 | -25.24% | 126 | 13.51% |
30 Jun, 20 | 397 | 10.58% | 111,436,124 | 2.92% | 96.98% | 1.05% | 210 | 21.39% | 111 | 11.00% |
31 Mar, 20 | 359 | 4.36% | 108,277,553 | 2.42% | 96.03% | 1.03% | 173 | - | 100 | 5.26% |
31 Dec, 19 | 344 | 11.33% | 105,718,192 | -2.06% | 96.75% | 0.98% | 173 | 20.98% | 95 | 23.38% |
30 Sep, 19 | 309 | -1.28% | 107,943,373 | 1.85% | 99.30% | 1.04% | 143 | -7.14% | 77 | - |
30 Jun, 19 | 313 | -0.32% | 105,982,622 | 9.50% | 97.61% | 1.16% | 154 | 0.65% | 77 | -11.49% |
31 Mar, 19 | 314 | 2.28% | 96,786,567 | 4.73% | 91.83% | 1.10% | 153 | 10.87% | 87 | -12.12% |
31 Dec, 18 | 307 | -10.50% | 92,415,190 | 1.95% | 91.44% | 1.13% | 138 | -10.39% | 99 | 6.45% |
30 Sep, 18 | 343 | 2.08% | 90,651,136 | -0.94% | 89.95% | 1.09% | 154 | -13.48% | 93 | 13.41% |
30 Jun, 18 | 336 | 4.35% | 91,515,814 | -0.14% | 91.04% | 1.08% | 178 | 7.23% | 82 | -6.82% |
31 Mar, 18 | 322 | 4.21% | 91,640,033 | -0.57% | 91.66% | 1.00% | 166 | -4.60% | 88 | 22.22% |
31 Dec, 17 | 309 | 11.96% | 92,168,593 | 5.31% | 95.87% | 1.06% | 174 | 45.00% | 72 | -14.29% |
30 Sep, 17 | 276 | 10.84% | 87,520,466 | 0.35% | 95.31% | 0.97% | 120 | -8.40% | 84 | 29.23% |
30 Jun, 17 | 249 | 10.67% | 87,213,397 | 5.97% | 99.00% | 1.08% | 131 | 32.32% | 65 | -8.45% |
31 Mar, 17 | 225 | -2.17% | 82,298,894 | 2.97% | 95.67% | 1.10% | 99 | -10.81% | 71 | -1.39% |
31 Dec, 16 | 230 | -18.73% | 79,928,117 | 3.07% | 93.38% | 1.14% | 111 | -3.48% | 72 | -18.18% |
30 Sep, 16 | 283 | 4.81% | 77,546,983 | 4.63% | 90.47% | 1.21% | 115 | -20.69% | 88 | 41.94% |
30 Jun, 16 | 270 | -2.17% | 74,115,161 | 2.82% | 86.64% | 1.21% | 145 | -2.03% | 62 | -1.59% |
31 Mar, 16 | 276 | 1.10% | 72,084,599 | 9.15% | 84.53% | 1.37% | 148 | 5.71% | 63 | -17.11% |
31 Dec, 15 | 273 | -0.36% | 66,043,326 | -14.28% | 78.63% | 0.95% | 140 | 6.87% | 76 | -12.64% |
30 Sep, 15 | 274 | -7.12% | 77,043,364 | 17.50% | 91.03% | 1.51% | 131 | -24.28% | 87 | 6.10% |
30 Jun, 15 | 295 | 15.69% | 65,567,282 | 1.69% | 77.73% | 1.26% | 173 | 14.57% | 82 | 32.26% |
31 Mar, 15 | 255 | 11.35% | 64,475,420 | 11.14% | 78.56% | 1.29% | 151 | 39.81% | 62 | -27.91% |
31 Dec, 14 | 229 | 15.66% | 58,012,605 | -1.64% | 78.10% | 1.31% | 108 | 30.12% | 86 | 28.36% |
30 Sep, 14 | 198 | -6.16% | 58,982,649 | 2.07% | 77.19% | 1.33% | 83 | -18.63% | 67 | -8.22% |
30 Jun, 14 | 211 | -2.76% | 57,784,900 | 3.73% | 76.20% | 1.13% | 102 | -12.82% | 73 | 15.87% |
31 Mar, 14 | 217 | 19.89% | 55,705,226 | 0.73% | 82.18% | 1.06% | 117 | 32.95% | 63 | -7.35% |
31 Dec, 13 | 181 | -0.55% | 55,301,194 | 7.94% | 87.91% | 1.30% | 88 | -16.98% | 68 | 28.30% |
30 Sep, 13 | 182 | 21.33% | 51,233,407 | 10.19% | 82.08% | 1.44% | 106 | -4.50% | 53 | 112.00% |
30 Jun, 13 | 150 | 154.24% | 46,496,933 | 97.84% | 75.41% | 4.78% | 111 | 164.29% | 25 | 212.50% |
31 Mar, 13 | 59 | 34.09% | 23,502,732 | 39.39% | 39.72% | 3.75% | 42 | 75.00% | 8 | -27.27% |
31 Dec, 12 | 44 | -20.00% | 16,861,031 | 5.78% | 32.54% | 3.40% | 24 | -29.41% | 11 | -8.33% |
30 Sep, 12 | 55 | 25.00% | 15,939,542 | -12.16% | 30.93% | 2.47% | 34 | 36.00% | 12 | 20.00% |
30 Jun, 12 | 44 | -6.38% | 18,146,235 | -9.37% | 35.39% | 1.88% | 25 | -26.47% | 10 | 66.67% |
31 Mar, 12 | 47 | 20.51% | 20,022,783 | 62.30% | 43.33% | 5.12% | 34 | 30.77% | 6 | -14.29% |
31 Dec, 11 | 39 | 25.81% | 12,336,694 | 7.12% | 29.09% | 3.99% | 26 | 62.50% | 7 | - |
30 Sep, 11 | 31 | - | 11,516,326 | -14.30% | 27.00% | 2.69% | 16 | - | 7 | -22.22% |
30 Jun, 11 | 31 | -3.13% | 13,437,262 | 83.04% | 31.71% | 10.55% | 16 | - | 9 | 12.50% |
31 Mar, 11 | 32 | 3.23% | 7,341,131 | 34.06% | 17.34% | 10.22% | 16 | -23.81% | 8 | 300.00% |
31 Dec, 10 | 31 | 34.78% | 5,475,993 | 85.01% | 13.03% | 26.38% | 21 | 133.33% | 2 | -66.67% |
30 Sep, 10 | 23 | -8.00% | 2,959,763 | -9.18% | 7.03% | 11.67% | 9 | -25.00% | 6 | -14.29% |
30 Jun, 10 | 25 | 19.05% | 3,258,845 | -23.89% | 7.76% | 7.42% | 12 | 20.00% | 7 | 16.67% |
31 Mar, 10 | 21 | -4.55% | 4,281,801 | 21.55% | 10.23% | 14.45% | 10 | - | 6 | 20.00% |
31 Dec, 09 | 22 | -18.52% | 3,522,595 | -4.62% | 8.41% | 10.73% | 10 | -16.67% | 5 | -16.67% |
30 Sep, 09 | 27 | -22.86% | 3,693,347 | 15.21% | 8.86% | 14.85% | 12 | -42.86% | 6 | -33.33% |
30 Jun, 09 | 35 | 9.38% | 3,205,857 | -65.73% | 7.72% | 1.51% | 21 | -16.00% | 9 | 80.00% |
31 Mar, 09 | 32 | -13.51% | 9,354,874 | -27.95% | 22.60% | 2.26% | 25 | -16.67% | 5 | - |
31 Dec, 08 | 37 | 27.59% | 12,983,088 | 262.33% | 31.61% | 41.78% | 30 | 87.50% | 5 | -50.00% |
30 Sep, 08 | 29 | 7.41% | 3,583,262 | 6.43% | 8.70% | 12.84% | 16 | -11.11% | 10 | 100.00% |
30 Jun, 08 | 27 | -10.00% | 3,366,795 | -1.57% | 8.23% | 11.67% | 18 | -5.26% | 5 | -28.57% |
31 Mar, 08 | 30 | -3.23% | 3,420,618 | -59.04% | 8.40% | 1.99% | 19 | 5.56% | 7 | - |
31 Dec, 07 | 31 | 40.91% | 8,351,692 | 0.84% | 20.53% | 4.56% | 18 | 157.14% | 7 | -30.00% |
30 Sep, 07 | 22 | -15.38% | 8,282,366 | -15.77% | 21.22% | 3.09% | 7 | -50.00% | 10 | 66.67% |
30 Jun, 07 | 26 | 4.00% | 9,833,574 | 125.52% | 26.20% | 19.25% | 14 | -26.32% | 6 | 50.00% |
31 Mar, 07 | 25 | 4.17% | 4,360,486 | -53.54% | 11.67% | 1.85% | 19 | 18.75% | 4 | - |
31 Dec, 06 | 24 | 9.09% | 9,386,143 | 10.86% | 25.11% | 3.61% | 16 | - | 4 | 300.00% |
30 Sep, 06 | 22 | 37.50% | 8,466,374 | 37.12% | 26.36% | 7.08% | 16 | 33.33% | 1 | - |
30 Jun, 06 | 16 | 14.29% | 6,174,506 | 112.92% | 19.29% | 20.68% | 12 | 20.00% | - | -100.00% |
31 Mar, 06 | 14 | 100.00% | 2,899,862 | 307.93% | 9.66% | 92.07% | 10 | 100.00% | 2 | 100.00% |
31 Dec, 05 | 7 | -12.50% | 710,870 | -79.66% | 3.24% | 1.16% | 5 | -28.57% | 1 | - |
30 Sep, 05 | 8 | 166.67% | 3,494,690 | 853.34% | 16.71% | 528.00% | 7 | 133.33% | 1 | - |
30 Jun, 05 | 3 | -25.00% | 366,572 | 68.14% | 1.78% | 156.29% | 3 | 200.00% | - | -100.00% |
31 Mar, 05 | 4 | 33.33% | 218,017 | -83.89% | 1.07% | 2.43% | 1 | -66.67% | 2 | - |
31 Dec, 04 | 3 | 200.00% | 1,353,710 | 19.78% | 6.62% | 21.66% | 3 | - | - | -100.00% |
30 Sep, 04 | 1 | - | 1,130,200 | -13.01% | 5.53% | 1.60% | - | -100.00% | 1 | - |
30 Jun, 04 | 1 | - | 1,299,293 | - | 18.57% | - | 1 | - | - | - |
Alnylam Pharmaceuticals Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
---|
Insider Sells
All Insider Owners Trades
The last insider sell of Alnylam Pharmaceuticals's stock was made by Fitzgerald Kevin Joseph on Aug 14 2024, selling 1,421 shares at $268.66 per share (valued at $381.77K).
Alnylam Pharmaceuticals Insider Ownership Trends
All Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q3 2024 | 5 | 20 | 25.00% |
Q2 2024 | 21 | 72 | 29.17% |
Q1 2024 | 19 | 62 | 30.65% |
Q4 2023 | 1 | 2 | 50.00% |
Q3 2023 | 9 | 35 | 25.71% |
Q2 2023 | 15 | 32 | 46.88% |
Q1 2023 | 25 | 29 | 86.21% |
Q4 2022 | 5 | 11 | 45.45% |
Q3 2022 | 17 | 37 | 45.95% |
Q2 2022 | 17 | 12 | 141.67% |
Q1 2022 | 14 | 4 | 350.00% |
Q4 2021 | 11 | 45 | 24.44% |
Q3 2021 | 19 | 18 | 105.56% |
Q2 2021 | 8 | 30 | 26.67% |
Q1 2021 | 19 | 36 | 52.78% |
Q4 2020 | 4 | 13 | 30.77% |
Q3 2020 | 26 | 34 | 76.47% |
Q2 2020 | 14 | 32 | 43.75% |
Q1 2020 | 21 | 32 | 65.63% |
Q4 2019 | 23 | 20 | 115.00% |
5 total buy trades, and 20 total sell trades (buy/sell ratio of 0.25%) were made by Alnylam Pharmaceuticals's insiders, as of Q3 2024.
Open Market Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q3 2024 | - | 15 | - |
Q2 2024 | - | 67 | - |
Q1 2024 | - | 46 | - |
Q4 2023 | - | 1 | - |
Q3 2023 | - | 34 | - |
Q2 2023 | - | 32 | - |
Q1 2023 | - | 19 | - |
Q4 2022 | - | 1 | - |
Q3 2022 | - | 16 | - |
Q2 2022 | - | 10 | - |
Q1 2022 | - | 1 | - |
Q4 2021 | - | 22 | - |
Q3 2021 | - | 10 | - |
Q2 2021 | - | 17 | - |
Q1 2021 | - | 18 | - |
Q4 2020 | - | 9 | - |
Q3 2020 | - | 16 | - |
Q2 2020 | - | 13 | - |
Q1 2020 | - | 19 | - |
Q4 2019 | - | 9 | - |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 15 open market sell trades of Alnylam Pharmaceuticals's stocks.
Alnylam Pharmaceuticals Peer Ownership
Ticker | Company |
---|---|
INCY | Incyte Corporation |
APLS | Apellis Pharmaceuticals, Inc. |
BPMC | Blueprint Medicines Corporation |
HALO | Halozyme Therapeutics, Inc. |
EXEL | Exelixis, Inc. |
DAWN | Day One Biopharmaceuticals, Inc. |
BMRN | BioMarin Pharmaceutical Inc. |
PRQR | ProQR Therapeutics N.V. |
WVE | Wave Life Sciences Ltd. |
KRYS | Krystal Biotech, Inc. |
UTHR | United Therapeutics Corporation |
KRTX | Karuna Therapeutics, Inc. |
RARE | Ultragenyx Pharmaceutical Inc. |
MDGL | Madrigal Pharmaceuticals, Inc. |
AMLX | Amylyx Pharmaceuticals, Inc. |
ALNY Ownership FAQ
Who Owns Alnylam Pharmaceuticals?
Alnylam Pharmaceuticals is owned by institutional shareholders (95.02%), insiders (0.42%), and public (4.56%). The largest institutional shareholder of Alnylam Pharmaceuticals is CAPITAL WORLD INVESTORS (11.87% of total shares) and the top mutual fund owner is AMERICAN CENTURY GROWTH FUNDS, INC. (1.21% of total shares).
Who are the major institutional shareholders of Alnylam Pharmaceuticals?
Alnylam Pharmaceuticals's major institutional shareholders are CAPITAL WORLD INVESTORS, VANGUARD GROUP INC, FMR LLC, BLACKROCK INC., and WELLINGTON MANAGEMENT GROUP LLP. The top five shareholders own together 43.92% of the company's share outstanding.
How many Alnylam Pharmaceuticals shareholders are there?
As of Jun 2024, there are 560 institutional shareholders of Alnylam Pharmaceuticals.
What percentage of Alnylam Pharmaceuticals is owned by CAPITAL WORLD INVESTORS?
CAPITAL WORLD INVESTORS owns 14.97M shares of Alnylam Pharmaceuticals, representing 11.87% of the company's total shares outstanding, valued at $3.64B (as of Jun 2024).
What percentage of Alnylam Pharmaceuticals is owned by VANGUARD GROUP INC?
As of Jun 2024, VANGUARD GROUP INC holds 12.51M shares of Alnylam Pharmaceuticals (ALNY), compromising 9.92% of the company, valued at $3.04B.
What percentage of Alnylam Pharmaceuticals is owned by FMR LLC?
FMR LLC is the third largest holder of Alnylam Pharmaceuticals. The company owns 12.16M of the company's shares outstanding (worth $2.96B).